Atlas Trials

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Clinical trial NCT03522545 · RECRUITING

Trial details

NCT number
NCT03522545
Sponsor
The University of Texas Health Science Center, Houston
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Treatment-resistant Bipolar Depression
Start date
2022-04-20
Primary completion
2026-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.